News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fluxion Biosciences Announces Early Access Program for IsoFlux™ Rare Cell Access System



9/21/2011 10:35:47 AM

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, Inc. announced today that it has launched an Early Access Program for its IsoFlux Rare Cell Access System. The program will enable scientists to incorporate circulating tumor cells (CTC) and other rare cell assays into their research prior to the IsoFlux commercial product release.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES